Camilla Westergaard Borgen

Camilla Westergaard Borgen is a seasoned professional with extensive experience in commercial strategy and leadership roles within the life sciences industry. Currently serving as Senior Director and Head of Commercial Strategy & Partnering at Zealand Pharma since November 2017, Camilla focuses on optimizing the value potential of pipeline assets and supporting R&D portfolio decisions with market insights. Additionally, Camilla holds a Board Member position at Ellegaard Göttingen Minipigs, contributing to the advancement of biomedical research. Previous roles include Executive Advisor at CWBorgen, Partner at ORBESEN, and Project Leader at The Boston Consulting Group, where Camilla specialized in corporate strategy and business development. Camilla's educational background includes a Cand. Merc FSM in Finance and Strategic Management from Copenhagen Business School and a Master's degree in Finance and Strategy from the University of Calgary.